Cargando…

The 6-min walk test as a primary end-point in interstitial lung disease

There is a need for clinical trial end-points to better assess how patients feel and function, so that interventions can be developed which alleviate symptoms and improve quality of life. Use of 6-min walk test (6MWT) outcomes as a primary end-point in interstitial lung disease (ILD) trials is growi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harari, Sergio, Wells, Athol U., Wuyts, Wim A., Nathan, Steven D., Kirchgaessler, Klaus-Uwe, Bengus, Monica, Behr, Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724818/ https://www.ncbi.nlm.nih.gov/pubmed/36002171 http://dx.doi.org/10.1183/16000617.0087-2022

Ejemplares similares

A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease
por: Maher, Toby M., et al.
Publicado: (2022)

Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study
por: Wijsenbeek, Marlies, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management
por: van Cleemput, Johan, et al.
Publicado: (2018)

Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study
por: Wijsenbeek, Marlies S., et al.
Publicado: (2021)

Comorbidities in interstitial lung diseases
por: Margaritopoulos, George A., et al.
Publicado: (2017)

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
por: Cottin, Vincent, et al.
Publicado: (2018)

Interstitial Lung Abnormalities: An Evolving Entity
por: Tomassetti, Sara, et al.
Publicado: (2022)

The role of precision medicine in interstitial lung disease
por: Maher, Toby M., et al.
Publicado: (2022)

Effect of Ambulatory Oxygen on the Respiratory Pattern during the 6 Min Walking Test in Patients with Interstitial Lung Diseases
por: Ventura, Vittoria, et al.
Publicado: (2023)

Smoking and interstitial lung diseases
por: Margaritopoulos, George A., et al.
Publicado: (2015)

Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
por: Brown, Kevin K., et al.
Publicado: (2020)

Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019)

Features and predictive value of 6-min walk test outcomes in interstitial lung disease: an observation study using wearable monitors
por: Li, Jiaying, et al.
Publicado: (2022)

Interstitial pneumonia with autoimmune features: challenges and controversies
por: Mackintosh, John A., et al.
Publicado: (2021)

Interstitial lung diseases: course report
por: Kreuter, Michael, et al.
Publicado: (2019)

Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry
por: Wuyts, Wim A, et al.
Publicado: (2018)

The modified Borg/6-min walk distance ratio: a method to assess exertional breathlessness and leg discomfort using the 6-min walk test
por: Ekström, Magnus, et al.
Publicado: (2023)

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
por: Costabel, Ulrich, et al.
Publicado: (2019)

Personalised medicine in interstitial lung diseases: Number 6 in the Series “Personalised medicine in respiratory diseases” Edited by Renaud Louis and Nicolas Roche
por: Kokosi, Maria A., et al.
Publicado: (2018)

Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry
por: Wuyts, Wim A., et al.
Publicado: (2022)

Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use
por: Kreuter, Michael, et al.
Publicado: (2021)

Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges
por: Kewalramani, Namrata, et al.
Publicado: (2022)

Cellular interactions in the pathogenesis of interstitial lung diseases
por: Bagnato, Gianluca, et al.
Publicado: (2015)

Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry
por: Wuyts, Wim A., et al.
Publicado: (2019)

Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
por: Funke-Chambour, Manuela, et al.
Publicado: (2022)

Repeatability of the 6-min walk test in non-cystic fibrosis bronchiectasis
por: Rovedder, Paula Maria Eidt, et al.
Publicado: (2020)

Walking 200 min per day keeps the bariatric surgeon away
por: Pfaff, Daniel H., et al.
Publicado: (2023)

Reference standards for the 6-min walk test in Croatian older adults
por: Sagat, Peter
Publicado: (2023)

Differences in Walking Pattern during 6-Min Walk Test between Patients with COPD and Healthy Subjects
por: Annegarn, Janneke, et al.
Publicado: (2012)

Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
por: Harari, Sergio
Publicado: (2018)

Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post-hoc Analysis
por: Molina-Molina, Maria, et al.
Publicado: (2022)

Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives
por: Tomassetti, Sara, et al.
Publicado: (2022)

FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
por: Nathan, Steven D., et al.
Publicado: (2020)

Dynamic hyperinflation during the 6-min walk test in severely asthmatic subjects
por: Benfante, Alida, et al.
Publicado: (2018)

Feasibility of Serial 6-min Walk Tests in Patients with Acute Heart Failure
por: Collins, Sean P., et al.
Publicado: (2017)

Heart rate monitoring improves clinical assessment during 6-min walk
por: Lachant, Daniel J., et al.
Publicado: (2020)

Limitations of a 6-min walk test to assess the efficacy of menthol for breathlessness
por: Kanezaki, Masashi, et al.
Publicado: (2022)

Stair walking effects on feelings of energy and fatigue: Is 4-min enough for benefits?
por: Carmichael, Kaitlyn E., et al.
Publicado: (2022)

Non-specific interstitial pneumonia in cigarette smokers: a CT study
por: Marten, Katharina, et al.
Publicado: (2009)

Acute Exacerbation in Interstitial Lung Disease
por: Leuschner, Gabriela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1u4vhjrg94kbjrc19snnetrkcn